These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30320206)

  • 1. Role of Nitric Oxide-Releasing Chitosan Oligosaccharides on Mucus Viscoelasticity.
    Reighard KP; Ehre C; Rushton ZL; Ahonen MJR; Hill DB; Schoenfisch MH
    ACS Biomater Sci Eng; 2017; 3(6):1017-1026. PubMed ID: 30320206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucolytic activity of bacterial and human chitinases.
    Sanders NN; Eijsink VG; van den Pangaart PS; Joost van Neerven RJ; Simons PJ; De Smedt SC; Demeester J
    Biochim Biophys Acta; 2007 May; 1770(5):839-46. PubMed ID: 17321686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiofilm and mucolytic action of nitric oxide delivered via gas or macromolecular donor using in vitro and ex vivo models.
    Rouillard KR; Hill DB; Schoenfisch MH
    J Cyst Fibros; 2020 Nov; 19(6):1004-1010. PubMed ID: 32205069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide-releasing alginates as mucolytic agents.
    Ahonen MJR; Hill DB; Schoenfisch MH
    ACS Biomater Sci Eng; 2019 Jul; 5(7):3409-3418. PubMed ID: 32309634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption and eradication of P. aeruginosa biofilms using nitric oxide-releasing chitosan oligosaccharides.
    Reighard KP; Hill DB; Dixon GA; Worley BV; Schoenfisch MH
    Biofouling; 2015; 31(9-10):775-87. PubMed ID: 26610146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A New Class of Safe Oligosaccharide Polymer Therapy To Modify the Mucus Barrier of Chronic Respiratory Disease.
    Pritchard MF; Powell LC; Menzies GE; Lewis PD; Hawkins K; Wright C; Doull I; Walsh TR; Onsøyen E; Dessen A; Myrvold R; Rye PD; Myrset AH; Stevens HN; Hodges LA; MacGregor G; Neilly JB; Hill KE; Thomas DW
    Mol Pharm; 2016 Mar; 13(3):863-72. PubMed ID: 26833139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of physicochemical properties of purified mucus glycoproteins isolated from respiratory secretions of cystic fibrosis and asthmatic patients.
    Chace KV; Flux M; Sachdev GP
    Biochemistry; 1985 Dec; 24(25):7334-41. PubMed ID: 3002452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved clearability of cystic fibrosis sputum with dextran treatment in vitro.
    Feng W; Garrett H; Speert DP; King M
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):710-4. PubMed ID: 9517580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidation increases mucin polymer cross-links to stiffen airway mucus gels.
    Yuan S; Hollinger M; Lachowicz-Scroggins ME; Kerr SC; Dunican EM; Daniel BM; Ghosh S; Erzurum SC; Willard B; Hazen SL; Huang X; Carrington SD; Oscarson S; Fahy JV
    Sci Transl Med; 2015 Feb; 7(276):276ra27. PubMed ID: 25717100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gel-forming mucin interactome drives mucus viscoelasticity.
    Demouveaux B; Gouyer V; Gottrand F; Narita T; Desseyn JL
    Adv Colloid Interface Sci; 2018 Feb; 252():69-82. PubMed ID: 29329667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of airways mucus: variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B.
    Kirkham S; Sheehan JK; Knight D; Richardson PS; Thornton DJ
    Biochem J; 2002 Feb; 361(Pt 3):537-46. PubMed ID: 11802783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structures of sulfated oligosaccharides in human trachea mucin glycoproteins.
    Sangadala S; Bhat UR; Mendicino J
    Mol Cell Biochem; 1993 Sep; 126(1):37-47. PubMed ID: 8107688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cervical mucus. III. Isolation and characterization of rheologically active mucin.
    Wolf DP; Sokoloski J; Khan MA; Litt M
    Fertil Steril; 1977 Jan; 28(1):53-8. PubMed ID: 832716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of mucus glycoproteins from cystic fibrotic sputum. Are there different families of mucins?
    Thornton DJ; Sheehan JK; Carlstedt I
    Biochem J; 1991 Jun; 276 ( Pt 3)(Pt 3):677-82. PubMed ID: 2064606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-Nitrosothiol-modified nitric oxide-releasing chitosan oligosaccharides as antibacterial agents.
    Lu Y; Shah A; Hunter RA; Soto RJ; Schoenfisch MH
    Acta Biomater; 2015 Jan; 12():62-69. PubMed ID: 25449913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additive effect of dornase alfa and Nacystelyn on transportability and viscoelasticity of cystic fibrosis sputum.
    Sun F; Tai S; Lim T; Baumann U; King M
    Can Respir J; 2002; 9(6):401-6. PubMed ID: 12522485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation and structures of oligosaccharide chains in human trachea mucin glycoproteins.
    Sangadala S; Bhat UR; Mendicino J
    Mol Cell Biochem; 1992 Dec; 118(1):75-90. PubMed ID: 1488058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of mucosal mucins separated by SDS-urea agarose polyacrylamide composite gel electrophoresis.
    Issa SM; Schulz BL; Packer NH; Karlsson NG
    Electrophoresis; 2011 Dec; 32(24):3554-63. PubMed ID: 22120911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of sulfated oligosaccharides by cystic fibrosis trachea epithelial cells.
    Mendicino J; Sangadala S
    Mol Cell Biochem; 1999 Nov; 201(1-2):141-9. PubMed ID: 10630633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions.
    Henke MO; Renner A; Huber RM; Seeds MC; Rubin BK
    Am J Respir Cell Mol Biol; 2004 Jul; 31(1):86-91. PubMed ID: 14988081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.